Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) Per Share - Antidilutive Securities (Details)

v3.21.2
Net Income (Loss) Per Share - Antidilutive Securities (Details) - shares
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 12,935,243 8,044,407 9,938,201 8,044,407
Options to purchase common stock        
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 405,638 600,924 0 600,924
Unvested RSUs and PSUs        
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 2,161,056 1,922,978 39,652 1,922,978
Warrants        
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 470,000 470,000 0 470,000
Convertible Notes        
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 9,898,549 5,050,505 9,898,549 5,050,505